Valink Therapeutics

Valink Therapeutics is a biotechnology company focused on developing innovative therapeutics aimed at treating cancer more effectively while minimizing harm to healthy tissue. The company's approach centers around creating next-generation antibody-drug conjugates (ADCs) that enhance the interaction between antibodies and tumor cells. This strategic focus allows Valink to address challenges such as drug resistance and the need for improved patient outcomes in oncology. Their mission is to differentiate between diseased and healthy cells, thereby reducing side effects and enabling the developmen…